» Articles » PMID: 36769560

Diabetic Retinopathy: Soluble and Imaging Ocular Biomarkers

Overview
Journal J Clin Med
Specialty General Medicine
Date 2023 Feb 11
PMID 36769560
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetic retinopathy (DR), the most common microvascular complication of diabetes mellitus, represents the leading cause of acquired blindness in the working-age population. Due to the potential absence of symptoms in the early stages of the disease, the identification of clinical biomarkers can have a crucial role in the early diagnosis of DR as well as for the detection of prognostic factors. In particular, imaging techniques are fundamental tools for screening, diagnosis, classification, monitoring, treatment planning and prognostic assessment in DR. In this context, the identification of ocular and systemic biomarkers is crucial to facilitate the risk stratification of diabetic patients; moreover, reliable biomarkers could provide prognostic information on disease progression as well as assist in predicting a patient's response to therapy. In this context, this review aimed to provide an updated and comprehensive overview of the soluble and anatomical biomarkers associated with DR.

Citing Articles

Tear-fluid-derived biomarkers of ocular complications in diabetes: a systematic review and meta-analysis.

Polkamp M, Pham N, Wong W, Hardikar H, Kunte P, Cameron M BMC Med. 2025; 23(1):84.

PMID: 39939938 PMC: 11823092. DOI: 10.1186/s12916-025-03855-z.


Early Diabetic Retinopathy Evaluation With OCTA: A Study on Vascular Branching and Fragmentation.

Yu Y, Cui S, He Y, Zhang J, Lu N, Yang Y Invest Ophthalmol Vis Sci. 2024; 65(14):21.

PMID: 39656470 PMC: 11636659. DOI: 10.1167/iovs.65.14.21.


Application and progress of artificial intelligence technology in the segmentation of hyperreflective foci in OCT images for ophthalmic disease research.

Ying J, Li H, Zhang Y, Li W, Yi Q Int J Ophthalmol. 2024; 17(6):1138-1143.

PMID: 38895690 PMC: 11144766. DOI: 10.18240/ijo.2024.06.20.

References
1.
Abdelkader H, Patel D, McGhee C, Alany R . New therapeutic approaches in the treatment of diabetic keratopathy: a review. Clin Exp Ophthalmol. 2010; 39(3):259-70. DOI: 10.1111/j.1442-9071.2010.02435.x. View

2.
Tummanapalli S, Issar T, Yan A, Kwai N, Poynten A, Krishnan A . Corneal nerve fiber loss in diabetes with chronic kidney disease. Ocul Surf. 2019; 18(1):178-185. DOI: 10.1016/j.jtos.2019.11.010. View

3.
Tang J, Kern T . Inflammation in diabetic retinopathy. Prog Retin Eye Res. 2011; 30(5):343-58. PMC: 3433044. DOI: 10.1016/j.preteyeres.2011.05.002. View

4.
Russell J, Shi Y, Hinkle J, Scott N, Fan K, Lyu C . Longitudinal Wide-Field Swept-Source OCT Angiography of Neovascularization in Proliferative Diabetic Retinopathy after Panretinal Photocoagulation. Ophthalmol Retina. 2019; 3(4):350-361. PMC: 6482856. DOI: 10.1016/j.oret.2018.11.008. View

5.
Korei A, Istenes I, Papanas N, Kempler P . Small-Fiber Neuropathy: A Diabetic Microvascular Complication of Special Clinical, Diagnostic, and Prognostic Importance. Angiology. 2015; 67(1):49-57. DOI: 10.1177/0003319715583595. View